Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-01-06 @ 6:35 PM
Study NCT ID:
NCT01737294
Status:
COMPLETED
Last Update Posted:
2014-10-06
First Post:
2012-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observation of the Use of QUTENZA™ in Standard Clinical Practice
Sponsor:
Astellas Pharma Europe Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-22
First Submit QC Date:
None
Study First Post Date:
2012-11-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-03
Last Update Post Date:
2014-10-06
Last Update Post Date Type:
ESTIMATED